PAVmed (PAVM) Short Interest Ratio & Short Volume → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free PAVM Stock Alerts $1.74 -0.11 (-5.95%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability PAVmed Short Interest DataCurrent Short Volume356,400 sharesPrevious Short Volume396,500 sharesChange Vs. Previous Month-10.11%Dollar Volume Sold Short$944,460.00Short Interest Ratio / Days to Cover4.3Last Record DateFebruary 29, 2024Outstanding Shares9,170,000 sharesFloat Size6,660,000 sharesShort Percent of Float5.35%Today's Trading Volume63,186 sharesAverage Trading Volume65,313 sharesToday's Volume Vs. Average97% Short Selling PAVmed ? Sign up to receive the latest short interest report for PAVmed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPAVM Short Interest Over TimePAVM Days to Cover Over TimePAVM Percentage of Float Shorted Over Time Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. PAVmed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/2024356,400 shares $944,460.00 -10.1%5.4%4.3 $2.65 2/15/2024396,500 shares $787,052.50 +44.5%5.4%5.2 $1.99 1/31/2024274,400 shares $636,608.00 -10.8%3.8%3.9 $2.32 1/15/2024307,700 shares $1.01 million +14.9%3.8%4.8 $3.29 12/31/2023267,700 shares $1.10 million -1.5%3.7%4.8 $4.12 12/15/2023271,700 shares $1.01 million +27.2%3.7%5.7 $3.72 Get the Latest News and Ratings for PAVM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter. 11/30/2023213,600 shares $990,036.00 -93.5%3.0%4.8 $4.64 11/15/20233,270,000 shares $722,670.00 -9.4%N/A5.1 $0.22 10/31/20233,610,000 shares $943,293.00 -1.4%N/A5.2 $0.26 10/15/20233,660,000 shares $1.08 million +9.6%N/A5.2 $0.29 9/30/20233,340,000 shares $983,964.00 -8.2%N/A4.7 $0.29 9/15/20233,640,000 shares $1.16 million -10.3%N/A4.9 $0.32 8/31/20234,060,000 shares $1.27 million +1.5%N/A6.1 $0.31 8/15/20234,000,000 shares $1.22 million +2.3%N/A7.6 $0.31 7/31/20233,910,000 shares $1.47 million -7.1%N/A8.2 $0.38 7/15/20234,210,000 shares $1.64 million -4.5%N/A8.6 $0.39 6/30/20234,410,000 shares $1.80 million +4.8%N/A8.5 $0.41 6/15/20234,210,000 shares $1.76 million -8.5%N/A8.5 $0.42 5/31/20234,600,000 shares $1.85 million -8.6%N/A9.6 $0.40 5/15/20235,030,000 shares $2.54 million -2.3%N/A12 $0.50 4/30/20235,150,000 shares $2.27 million -5.9%N/A11.5 $0.44 4/15/20235,470,000 shares $2.41 million -1.8%N/A12.3 $0.44 3/31/20235,570,000 shares $2.08 million -21.9%6.7%12.2 $0.37 3/15/20237,130,000 shares $3.07 million -3.1%8.5%13.9 $0.43 2/28/20237,360,000 shares $3.41 million +14.8%9.2%13.2 $0.46 2/15/20236,410,000 shares $3.08 million +8.1%8.1%10.4 $0.48 1/31/20235,930,000 shares $3.03 million -11.4%N/A8.7 $0.51 1/15/20236,690,000 shares $3.91 million +13.4%N/A9.5 $0.59 12/30/20225,900,000 shares $2.83 million +8.5%N/A8.6 $0.48 12/15/20225,440,000 shares $2.79 million -0.4%N/A7.7 $0.51 11/30/20225,460,000 shares $3.82 million -1.8%N/A8 $0.70 11/15/20225,560,000 shares $5.35 million -5.1%N/A8.9 $0.96 10/31/20225,860,000 shares $7.27 million +3.9%7.1%7.1 $1.24 10/15/20225,640,000 shares $5.55 million +15.6%6.8%5.9 $0.98 9/30/20224,880,000 shares $4.20 million +6.1%5.9%5.2 $0.86 9/15/20224,600,000 shares $5.15 million -1.1%5.6%4.3 $1.12 8/31/20224,650,000 shares $5.53 million -21.3%5.6%4 $1.19 8/15/20225,910,000 shares $13.42 million -9.9%7.2%4.6 $2.27 7/31/20226,560,000 shares $7.94 million +2.2%8.2%5.2 $1.21 7/15/20226,420,000 shares $6.81 million -10.5%8.0%4.3 $1.06Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. PAVM Short Interest - Frequently Asked Questions What is PAVmed's current short interest? Short interest is the volume of PAVmed shares that have been sold short but have not yet been covered or closed out. As of February 29th, traders have sold 356,400 shares of PAVM short. 5.35% of PAVmed's shares are currently sold short. Learn More on PAVmed's current short interest. What is a good short interest ratio for PAVmed? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PAVM shares currently have a short interest ratio of 4.0. Learn More on PAVmed's short interest ratio. What is a good short interest percentage for PAVmed? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.35% of PAVmed's floating shares are currently sold short. Is PAVmed's short interest increasing or decreasing? PAVmed saw a drop in short interest in the month of February. As of February 29th, there was short interest totaling 356,400 shares, a drop of 10.1% from the previous total of 396,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is PAVmed's float size? PAVmed currently has issued a total of 9,170,000 shares. Some of PAVmed's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. PAVmed currently has a public float of 6,660,000 shares. How does PAVmed's short interest compare to its competitors? 5.35% of PAVmed's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to PAVmed: Meihua International Medical Technologies Co., Ltd. (1.61%), STRATA Skin Sciences, Inc. (0.86%), Akili, Inc. (0.15%), T2 Biosystems, Inc. (6.80%), PetVivo Holdings, Inc. (1.49%), GlucoTrack, Inc. (0.51%), NEXGEL, Inc. (0.37%), Biotricity, Inc. (5.62%), PolyPid Ltd. (0.15%), Microbot Medical Inc. (1.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short PAVmed stock? Short selling PAVM is an investing strategy that aims to generate trading profit from PAVmed as its price is falling. PAVM shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PAVmed? A short squeeze for PAVmed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PAVM, which in turn drives the price of the stock up even further. How often is PAVmed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PAVM, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: MHUA Short Interest SSKN Short Interest AKLI Short Interest TTOO Short Interest PETV Short Interest GCTK Short Interest NXGL Short Interest BTCY Short Interest PYPD Short Interest MBOT Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PAVM) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & Company